The stock of Beximco Pharmaceuticals Limited (LON:BXP) is a huge mover today! The stock increased 0.35% or GBX 0.18 on November 16, hitting GBX 51.68. About 111,753 shares traded hands or 94.17% up from the average. Beximco Pharmaceuticals Limited (LON:BXP) has risen 112.00% since April 20, 2016 and is uptrending. It has outperformed by 107.31% the S&P500.
The move comes after 7 months positive chart setup for the GBX 35.65B company. It was reported on Nov, 16 by Barchart.com. We have GBX 83.20 PT which if reached, will make LON:BXP worth GBX 21.75B more.
Another recent and important Beximco Pharmaceuticals Limited (LON:BXP) news was published by Uk.Finance.Yahoo.com which published an article titled: “Beximco Pharmaceuticals Limited (BXP.L)” on March 30, 2014.
Beximco Pharmaceuticals Limited is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The company has a market cap of 35.65 billion GBP. The Firm also provides contract manufacturing services. It has a 0.11 P/E ratio. The Firm produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology and gastrointestinal.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.